PetIQ said on Wednesday that it has agreed to be bought by New York-based private investment firm Bansk Group in a $1.5bn deal.
Petiq, Inc.
07 August 2024 14:31:16
Source: Sharecast
Under the terms of the agreement, PetIQ shareholders will receive $31.00 per share in cash, which is a 51% premium to the closing share price on Tuesday.
Cord Christensen, founder, chairman and chief executive of the pet medication, health and wellness company, said: "On behalf of PetIQ's board of directors, we are thrilled to announce the execution of a definitive agreement with Bansk Group at a substantial premium for PetIQ stockholders.
"After a comprehensive assessment of the offer with the assistance of our outside advisors, the board has determined that this transaction represents an attractive outcome for PetIQ and our stockholders."
The deal is expected to close in the fourth quarter.
At 1430 BST, the shares were up 48% at $30.51.
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
